Federal contract award

75H71221P00225

ON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PIMC

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficePHOENIX AREA INDIAN HEALTH SVC
NAICS621511 — Medical Laboratories
PSCR499 — Other Professional Services
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$454.4K
Current contract value$454.4K
Potential contract value / ceiling$454.4K
Start dateSep 27, 2021
Current end dateMar 30, 2027
Potential end dateMar 30, 2027
Latest award activityAug 10, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 10, 2026P00012$0ON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Jun 26, 2026P00011$55.6KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Jul 29, 2025P00010$15.3KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Jul 3, 2025P00009$96.0KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Feb 3, 2025P00008$0ON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Jan 29, 2025P00007$-106.9KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Dec 9, 2024P00006$0ON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Oct 17, 2024P00005$13.3KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Jul 22, 2024P00004$96.0KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
May 9, 2024P00003$12.0KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PHOENIX INDIAN MEDICAL CENTER
Jul 20, 2023P00002$92.2KEXERCISE OY2 FOR ON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PIMC
Aug 4, 2022P00001$92.2KEXERCISE OY1 AND ADD CLAUSES - ON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PIMC
Sep 27, 20210$88.5KON-SITE STEREOTACTIC BREAST BIOPSY SERVICES FOR PIMC

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
65/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 65/100. Available recorded signals: 60 points.

Contract end 2027-03-30 (149 days from calculation)
+35 points
1 historical awards in this buyer and category group
+0 points
13 recorded award transactions
+10 points
Latest award action: 2026-08-10
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Tochi AnicheContactTochukwu.Aniche@ihs.gov
6022455747
SourceSep 10, 2021
Felicia AspaasContactFelicia.Aspaas@ihs.gov
6023645032
SourceSep 10, 2021
Tochi AnicheContactTochukwu.Aniche@ihs.gov
6022455747
SourceSep 3, 2021
Felicia AspaasContactFelicia.Aspaas@ihs.gov
6023645032
SourceSep 3, 2021

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.